Form 8-K - Current report:
SEC Accession No. 0001193125-15-127576
Filing Date
2015-04-13
Accepted
2015-04-13 16:30:30
Documents
10
Period of Report
2015-04-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d906091d8k.htm 8-K 17926
2 EX-99.1 d906091dex991.htm EX-99.1 83649
3 GRAPHIC g906091ex99_1s1gbgd.jpg GRAPHIC 76743
4 GRAPHIC g906091ex99_1s2gbgd.jpg GRAPHIC 22620
5 GRAPHIC g906091ex99_1s3g1.jpg GRAPHIC 9453
6 GRAPHIC g906091ex99_1s3gbgd.jpg GRAPHIC 26447
7 GRAPHIC g906091ex99_1s4gbgd.jpg GRAPHIC 28605
8 GRAPHIC g906091ex99_1s5gbgd.jpg GRAPHIC 28456
9 GRAPHIC g906091ex99_1s6gbgd.jpg GRAPHIC 34610
10 GRAPHIC g906091ex99_1s7gbgd.jpg GRAPHIC 57742
  Complete submission text file 0001193125-15-127576.txt   496273
Mailing Address 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536
Business Address 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 15767022
SIC: 3826 Laboratory Analytical Instruments